Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC; REVERSE study group. Linde C, et al. Among authors: daubert jc. Eur Heart J. 2011 Jul;32(13):1631-9. doi: 10.1093/eurheartj/ehq408. Epub 2010 Nov 25. Eur Heart J. 2011. PMID: 21112898 Clinical Trial.
Predictors of short-term clinical response to cardiac resynchronization therapy.
Linde C, Abraham WT, Gold MR, Daubert JC, Tang ASL, Young JB, Sherfesee L, Hudnall JH, Fagan DH, Cleland JG. Linde C, et al. Among authors: daubert jc. Eur J Heart Fail. 2017 Aug;19(8):1056-1063. doi: 10.1002/ejhf.795. Epub 2017 Mar 14. Eur J Heart Fail. 2017. PMID: 28295869 Free article. Review.
Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Linde C, et al. Among authors: daubert jc. Am Heart J. 2006 Feb;151(2):288-94. doi: 10.1016/j.ahj.2005.03.002. Am Heart J. 2006. PMID: 16442890
Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials.
Nassif ME, Tang Y, Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Daubert JC, Sherfesee L, Schaber D, Tang ASL, Jones PG, Arnold SV, Spertus JA. Nassif ME, et al. Among authors: daubert jc. Circ Heart Fail. 2017 Oct;10(10):e004111. doi: 10.1161/CIRCHEARTFAILURE.117.004111. Circ Heart Fail. 2017. PMID: 29038172 Free PMC article.
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ; ESC Committee for Practice Guidelines (CPG). Dickstein K, et al. Among authors: daubert jc. Eur Heart J. 2010 Nov;31(21):2677-87. doi: 10.1093/eurheartj/ehq337. Epub 2010 Aug 27. Eur Heart J. 2010. PMID: 20801924 No abstract available.
306 results